This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yaglom, J. A. Articles by Sherman, M. Y. Search for Related Content PubMed PubMed Citation Articles by Yaglom, J. A. Articles by Sherman, M. Y.

High Levels of Heat Shock Protein Hsp72 in Cancer Cells Suppress Default Senescence Pathways

Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts

Requests for reprints: Michael Y. Sherman, Department of Biochemistry, Boston University Medical School, 715 Albany Street, Boston, MA 02118. Phone: 617-638-5971; Fax: 617-638-5339; E-mail: sherman{at}biochem.bumc.bu.edu.

The major heat shock protein Hsp72 is constitutively expressed in many tumor cell lines and biopsies, and its expression correlates with poor prognosis in several types of cancer. Hsp72 was suggested to play an important role in neoplastic transformation and tumor development. We addressed the role of Hsp72 in cancer cells by investigating the consequences of specific depletion of Hsp72 using small interfering RNA. Down-regulation of Hsp72 in certain cancer lines triggered cell senescence associated with activation and stabilization of p53 and induction of the cell cycle inhibitor p21. Effects of Hsp72 depletion on senescence and p53 did not result from a proteotoxic stress, DNA instability, or activation of ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related pathways. Instead, depletion of Hsp72 reduced stability and activity of the p53 inhibitor Hdm2. In addition, Hsp72 depletion triggered a p53-independent senescence program through inhibitory phosphorylation and down-regulation of the cell cycle kinase Cdc2. Therefore, Hsp72 provides a selective advantage to cancer cells by suppressing default senescence via p53-dependent and p53-independent pathways. [Cancer Res 2007;67(5):2373–81]

This article has been cited by other articles:

				K. Korhonen, S. Sjovall, J. Viitanen, E. Ketoja, A. Makarevich, and J. Peippo Viability of bovine embryos following exposure to the green filtered or wider bandwidth light during in vitro embryo production Hum. Reprod., February 1, 2009; 24(2): 308 - 314. [Abstract] [Full Text] [PDF]

				V. L. Gabai, J. A. Yaglom, T. Waldman, and M. Y. Sherman Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells Mol. Cell. Biol., January 15, 2009; 29(2): 559 - 569. [Abstract] [Full Text] [PDF]

				V. L. Gabai, C. O'Callaghan-Sunol, L. Meng, M. Y. Sherman, and J. Yaglom Triggering Senescence Programs Suppresses Chk1 Kinase and Sensitizes Cells To Genotoxic Stresses Cancer Res., March 15, 2008; 68(6): 1834 - 1842. [Abstract] [Full Text] [PDF]

				J. C. Ghosh, T. Dohi, B. H. Kang, and D. C. Altieri Hsp60 Regulation of Tumor Cell Apoptosis J. Biol. Chem., February 22, 2008; 283(8): 5188 - 5194. [Abstract] [Full Text] [PDF]

				C. O'Callaghan-Sunol, V. L. Gabai, and M. Y. Sherman Hsp27 Modulates p53 Signaling and Suppresses Cellular Senescence Cancer Res., December 15, 2007; 67(24): 11779 - 11788. [Abstract] [Full Text] [PDF]